| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/02/2009 | EP2094664A2 A new process for the preparation of montelukast |
| 09/02/2009 | EP2094646A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 09/02/2009 | EP0975597B1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 09/02/2009 | CN101522631A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ss2 adrenergic receptor |
| 09/02/2009 | CN101522630A 1H-quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 09/01/2009 | US7582762 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 08/27/2009 | WO2009103778A1 Compounds and methods |
| 08/27/2009 | WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 08/27/2009 | US20090215800 Enzyme and Receptor Modulation |
| 08/27/2009 | US20090215773 Dihydropyridine derivatives |
| 08/27/2009 | US20090215730 Antineoplastic compounds and pharmaceutical compositions thereof |
| 08/26/2009 | EP2093217A1 Polymorph and solvates of aripiprazole |
| 08/26/2009 | EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 08/26/2009 | EP2091527A2 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof |
| 08/26/2009 | EP1539700B1 8-hydroxy quinoline derivatives |
| 08/26/2009 | CN101516853A Quinolinone derivatives |
| 08/26/2009 | CN101516852A Quinoline derivatives with 5-HT-binding properties |
| 08/26/2009 | CN101516851A Quinolinylmethyl compounds |
| 08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101516819A Process and intermediates for preparing integrase inhibitors |
| 08/26/2009 | CN101514214A Novel red electroluminescent compounds and organic electroluminescent device using the same |
| 08/26/2009 | CN101514188A Method for preparing 8-hydroxyquinoline metal compounds |
| 08/26/2009 | CN101514187A Method for producing ethoxyquinoline |
| 08/26/2009 | CN100532362C Process for preparing N-methyl quinoline compounds by ester reaction solvent |
| 08/25/2009 | US7579473 c-Met modulators and methods of use |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/20/2009 | WO2009029317A3 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
| 08/20/2009 | US20090209580 Antitumor agent for thyroid cancer |
| 08/20/2009 | US20090209564 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use |
| 08/20/2009 | US20090206326 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 08/19/2009 | EP2090566A2 Certain phenylacetic acids and derivatives |
| 08/19/2009 | EP2089399A1 Polymerisation of ethylene and alpha olefins with single site catalysts having an anionic scorpion-like ligand |
| 08/19/2009 | EP1819689B1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides |
| 08/19/2009 | EP1513802B1 Alpha-sulfonylamino-acetonitriles |
| 08/19/2009 | EP1183240B1 Beta2-adrenoceptor agonists |
| 08/19/2009 | CN101511794A Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 08/19/2009 | CN101511793A Antitumor agent for undifferentiated gastric cancer |
| 08/19/2009 | CN101511362A Aqueous formulation comprising an antitumor agent |
| 08/19/2009 | CN101508705A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/19/2009 | CN101508673A Novel red electroluminescent compounds and organic electroluminescent device using the same |
| 08/19/2009 | CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same |
| 08/19/2009 | CN100528872C Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 08/19/2009 | CN100528821C Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/18/2009 | US7576217 Quinolines as allosteric enhancers of the GABAB receptors |
| 08/18/2009 | US7576216 Preparation of pyridonecarboxylic acid antibacterials |
| 08/18/2009 | US7576215 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 08/18/2009 | US7576214 Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1,8-naphthyridine-3-carboxylic acid |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576100 Muscarinic agonists |
| 08/18/2009 | US7576099 inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist; N-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-4-((E)-3,3-dimethyl-but-1-enyl)-benzamide; 6-(3,3-Dimethyl-but-1-ynyl)-N-guinolin-3-yl-nicotinamide |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2427831C Cyclization process step in the making of quinolones and naphthyridines |
| 08/18/2009 | CA2393568C Diarylmethylpiperazines |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098271A1 Process for the purification of montelukast by the preparation of acid addition salts and tert-amylamine salt |
| 08/13/2009 | US20090203693 Therapeutic agent for liver fibrosis |
| 08/13/2009 | US20090203685 Anti-proliferative compounds from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | CA2714181A1 Ampk modulators |
| 08/12/2009 | EP2088141A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| 08/12/2009 | EP2086945A2 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 08/12/2009 | EP2086941A1 Antibacterial quinoline derivatives |
| 08/12/2009 | EP2086940A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101506328A Organic electroluminescent device material and organic electroluminescent device |
| 08/12/2009 | CN101506170A 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor |
| 08/12/2009 | CN101506168A Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 08/12/2009 | CN101505751A 8-hydroxyquinoline compounds and methods thereof |
| 08/12/2009 | CN100526299C Process for preparing 8-hydroxy quinoline aluminum |
| 08/11/2009 | US7572917 Condensation of silicon compounds with aldehydes in the presence of titanium catalysts in solvents, then reducing and hydolyzing to form drugs used for prophylaxis of atherosclerosis or as enzyme inhibitors |
| 08/11/2009 | US7572916 For the preparation of (R)-(+)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl) methyl]-4-(3-chlorophenyl)-1-methyl2(1H)-quinolinone; farnesyl tranferase inhibitory activity |
| 08/11/2009 | US7572915 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/11/2009 | US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572810 Alkene piperidine derivatives as antiviral agents |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2222552C N-oxides as antibacterial agents |
| 08/06/2009 | WO2009097433A1 Novel dyes and use thereof in imaging members and methods |
| 08/06/2009 | WO2009097278A1 6-SUBSTITUTED-THIO-2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009096377A1 Combined use of angiogenesis inhibitor and taxane |
| 08/06/2009 | WO2009095872A2 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 08/06/2009 | WO2009053424A9 Crystalline salt of montelukast |
| 08/06/2009 | US20090198059 Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts |
| 08/06/2009 | US20090197888 Fluorinated tripeptide hcv serine protease inhibitors |
| 08/06/2009 | US20090197878 SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR |
| 08/06/2009 | US20090197834 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 08/06/2009 | CA2713998A1 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of.beta.-secretase (bace) |
| 08/06/2009 | CA2713930A1 Combined use of angiogenesis inhibitor and taxane |
| 08/05/2009 | EP2085390A1 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085386A2 Pyridinium and quinolinium derivatives as Choline kinase inhibitors |